Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for GSK PLC Sponsored ADR (GSK : NYSE)
 
 • Company Description   
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.

Number of Employees: 68,629

 
 • Price / Volume Information   
Yesterday's Closing Price: $43.78 Daily Weekly Monthly
20 Day Moving Average: 5,942,613 shares
Shares Outstanding: 2,034.42 (millions)
Market Capitalization: $89,066.68 (millions)
Beta: 0.53
52 Week High: $45.59
52 Week Low: $31.72
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 8.47% 7.32%
12 Week 15.12% 9.73%
Year To Date 29.45% 14.13%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
79 New Oxford Street
-
London,X0 WC1A 1DG
GBR		 ph: 44-20-8047-5000
fax: 44-20-8047-7807		 gsk.investor-relations@gsk.com http://www.gsk.com
 
 • General Corporate Information   
Officers
Dame Emma Walmsley - Chief Executive Officer
Jonathan Symonds - Chairman
Julie Brown - Chief Financial Officer
Charles Bancroft - Director
Hal Barron - Director

Peer Information
GSK PLC Sponsored ADR (CORR.)
GSK PLC Sponsored ADR (RSPI)
GSK PLC Sponsored ADR (CGXP)
GSK PLC Sponsored ADR (BGEN)
GSK PLC Sponsored ADR (GTBP)
GSK PLC Sponsored ADR (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 37733W204
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 10/29/25
Share - Related Items
Shares Outstanding: 2,034.42
Most Recent Split Date: 7.00 (0.80:1)
Beta: 0.53
Market Capitalization: $89,066.68 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 3.86%
Current Fiscal Quarter EPS Consensus Estimate: $0.69 Indicated Annual Dividend: $1.69
Current Fiscal Year EPS Consensus Estimate: $4.38 Payout Ratio: 0.41
Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: -0.09
Estmated Long-Term EPS Growth Rate: 5.07% Last Dividend Paid: 08/15/2025 - $0.42
Next EPS Report Date: 10/29/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 9.99
Trailing 12 Months: 10.37
PEG Ratio: 1.97
Price Ratios
Price/Book: 4.66
Price/Cash Flow: 7.85
Price / Sales: 2.17
EPS Growth
vs. Year Ago Period: 12.84%
vs. Previous Quarter: 8.85%
Sales Growth
vs. Year Ago Period: 7.23%
vs. Previous Quarter: 12.71%
ROE
09/30/25 - -
06/30/25 - 49.22
03/31/25 - 48.82
ROA
09/30/25 - -
06/30/25 - 11.31
03/31/25 - 11.15
Current Ratio
09/30/25 - -
06/30/25 - 0.87
03/31/25 - 0.87
Quick Ratio
09/30/25 - -
06/30/25 - 0.57
03/31/25 - 0.58
Operating Margin
09/30/25 - -
06/30/25 - 21.21
03/31/25 - 20.87
Net Margin
09/30/25 - -
06/30/25 - 10.81
03/31/25 - 9.89
Pre-Tax Margin
09/30/25 - -
06/30/25 - 14.68
03/31/25 - 13.37
Book Value
09/30/25 - -
06/30/25 - 9.40
03/31/25 - 8.34
Inventory Turnover
09/30/25 - -
06/30/25 - 1.53
03/31/25 - 1.54
Debt-to-Equity
09/30/25 - -
06/30/25 - 1.07
03/31/25 - 1.21
Debt-to-Capital
09/30/25 - -
06/30/25 - 51.60
03/31/25 - 54.68
 

Powered by Zacks Investment Research ©